Johnson & Johnson
(XTER:JNJ)
€
146.52
-1.08 (-0.73%)
Market Cap: 352.08 Bil
Enterprise Value: 366.43 Bil
PE Ratio: 10.19
PB Ratio: 5.49
GF Score: 75/100 Johnson & Johnson at Morgan Stanley Global Healthcare Conference Transcript
Sep 14, 2022 / 03:10PM GMT
Release Date Price:
€164.3
(+1.07%)
Terence C. Flynn
Morgan Stanley, Research Division - Equity Analyst
Great. Well, thanks for joining us, everybody. I'm Terence Flynn, the U.S. pharma analyst at Morgan Stanley. We're very pleased to have Johnson & Johnson with us today. Just quickly before we get started, for important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
Today from the company, we have Joaquin Duato, the company's CEO; and Joe Wolk, Executive Vice President and CFO. Thank you both so much for being here. Great to see you in person.
Joseph J. Wolk
Johnson & Johnson - Executive VP & CFO
Nice to see you, Terence.
Joaquin Duato
Johnson & Johnson - CEO & Director
Thank you. Thanks for having us.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot